Syn2bio S.A. (S2B.WA) — Stock Score Summary

Syn2bio S.A. (S2B.WA) has a MoatMap StockRank of 1/100 based on Quality (21/100), Value (25/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL. Syn2bio S.A. is a micro-cap Polish healthcare company lacking the scale, high ROIC, and established pricing power required by our Terry Smith and Warren Buffett lenses. With a quantitative Strong Sell signal and no clear path to global market dominance, it fails to present an asymmetric risk-reward profile.

Syn2bio S.A. is a biotechnology company focused on developing innovative biomedical solutions and advanced therapies. The company's competitive moat is its proprietary research platform and focus on high-potential niche applications in regenerative medicine or diagnostics. It operates as an early-stage, high-risk, high-reward biotech innovator.

Key Financial Metrics

Price$8.91
Market Cap$85M
Return on Invested Capital-166.2%
Gross Margin0.0%
Operating Margin0.0%

Syn2bio S.A. operates in the Biotechnology industry, part of the Healthcare sector (Poland).

Frequently Asked Questions

What is Syn2bio S.A.’s (S2B.WA) StockRank?
MoatMap’s StockRank for Syn2bio S.A. (S2B.WA) is 1/100, with a Strong Sell signal. It is a composite of Quality (21), Value (25), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does Syn2bio S.A. have an economic moat?
Syn2bio S.A. (S2B.WA) has a Quality factor score of 21/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Syn2bio S.A. a buy, hold, or sell?
MoatMap’s current signal for Syn2bio S.A. (S2B.WA) is Strong Sell, based on a StockRank of 1/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Syn2bio S.A. in?
Syn2bio S.A. (S2B.WA) operates in the Healthcare sector, specifically the Biotechnology industry (Poland).
Browse all ranked stocksS2B.WA deep dive reportAI ChampionsHow we score stocksSense-check another stock